Most of those two weeks is not science. It is finding and assembling the data, which is also where most of the AI sold to pharma quietly stalls.
연구 및 보고서2026년 8월 30일•1분 읽기
AI in Pharma Faces Data‑Gathering Delays, Not Scientific Limits
A recent note says most of the two‑week deviation investigation time is spent on data collection, not science, highlighting a bottleneck for AI tools in pharma.
PharmaCountry 팀이 정리했습니다 · 출처: FiercePharma
평점
(0)
(0)
(0)
(0)
(0)
평가 남기기